India

India will likely take at least three to four months to complete Covid-19 vaccination efforts for frontline workers and people over 60 or with underlying health conditions, the executive director of the Serum Institute of India said…

China's Xiaomi had dominated the Indian smartphone market for three years in a row, until it recently lost top spot to Samsung. It has followed the Indian government's set of rules to support domestic…

An AstraZeneca vaccine production line.Bloomberg | Bloomberg | Getty ImagesThe world's largest vaccine maker by volume, Serum Institute of India, has been told to first meet domestic demand for Covid-19 shots before selling them…

A medical professional holds Covid-19 vaccine Covaxin vial during the nationwide vaccination campaign in Jaipur, Rajasthan, India, Saturday, February 6, 2021.Vishal Bhatnagar | NurPhoto | Getty ImagesIndia could become the second largest…

This article is part of the On Tech newsletter. You can sign up here to receive it on weekdays.A remarkable clash between an American internet company and the world's largest democracy takes place over the reasonable limits of freedom of…

NEW DELHI - India, the unmatched vaccine producer, is dispensing millions of doses to friendly and estranged neighbors. It seeks to counter China, which has made the gun distribution a central point of its external relations. And the…

The Twitter app is loading onto an iPhone in this illustration photo that was taken in Los Angeles, California.Mike Blake | ReutersIndia blamed Twitter for failing to promptly follow government instructions to remove certain content and…

NEW DELHI - Long before the floods came, washed away hundreds of people and wiped out newly built dams and bridges, the warning signs were clear.The Himalayas have been warming at an alarming rate for years, melting ice long trapped in…

Bangalore Airport employees transfer cardboard boxes of vials of Covishield vaccine developed by the Serum Institute of India on January 12, 2021 in Bangalore, India.Stringer | Xinhua | Getty ImagesSINGAPORE - India is preparing for one…

SINGAPORE - Indian drug maker Cadila Healthcare is about to start a phase 3 clinical trial for a potential coronavirus vaccine, its chairman told CNBC."We are now entering the third phase, which will begin very, very soon," Pankaj Patel…